Australia's Bioxyne rises to near 8-year high after company secures German supply deal

Bioxyne

12/05/2026 02:15

** Shares of Bioxyne BXN.AX rise as much as 18.1% to A$0.085, their highest level since May 21, 2018

** Stock logs its largest intraday pct jump since late June 2025

** The pharmaceutical firm says unit enters a two-year, A$50 million ($36.17 million) supply agreement with German partner ADREXpharma

** Agreement for the supply of unit's medical cannabis products in Germany

** More than 8.7 million shares change hands, 2.4 times the 30-day average

** Stock up 97.6% YTD, including the day's moves

($1 = 1.3824 Australian dollars)

 (Reporting by Nikita Maria Jino in Bengaluru)

 ((Nikita.Jino@thomsonreuters.com;))